HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yutaka Kawakami Selected Research

ACT regimen

8/2021Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yutaka Kawakami Research Topics

Disease

119Neoplasms (Cancer)
10/2023 - 02/2002
38Melanoma (Melanoma, Malignant)
01/2023 - 12/2002
16Glioma (Gliomas)
09/2022 - 01/2004
13Neoplasm Metastasis (Metastasis)
04/2019 - 02/2002
11Colorectal Neoplasms (Colorectal Cancer)
08/2023 - 09/2003
10Colonic Neoplasms (Colon Cancer)
01/2022 - 02/2002
9Fibrosis (Cirrhosis)
04/2021 - 06/2003
9Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
08/2008 - 04/2002
8Bronchiolitis Obliterans Syndrome
04/2021 - 12/2005
7Testicular Neoplasms (Testicular Cancer)
06/2017 - 05/2005
6Graft vs Host Disease (Graft-Versus-Host Disease)
06/2021 - 01/2006
6Glioblastoma (Glioblastoma Multiforme)
03/2020 - 04/2007
6Hematologic Neoplasms (Hematological Malignancy)
01/2018 - 03/2003
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2017 - 04/2004
5Brain Neoplasms (Brain Tumor)
09/2022 - 04/2002
5Squamous Cell Carcinoma of Head and Neck
01/2018 - 06/2013
4Lymphoma (Lymphomas)
10/2020 - 04/2010
4Extramammary Paget Disease (Paget Disease, Extramammary)
06/2020 - 01/2019
4Infections
01/2019 - 07/2004
4Systemic Scleroderma (Systemic Sclerosis)
06/2006 - 10/2002
3Spinal Cord Injuries (Spinal Cord Injury)
12/2022 - 07/2008
3Neurofibromatosis 2 (Neurofibromatosis Type II)
03/2020 - 12/2019
3Breast Neoplasms (Breast Cancer)
01/2019 - 05/2003
3Hypersensitivity (Allergy)
07/2018 - 05/2003
3Carcinogenesis
01/2018 - 07/2007
3Adenocarcinoma
11/2017 - 10/2005
3Microsatellite Instability
01/2017 - 09/2003
3Leukemia
01/2016 - 03/2003
3Carcinoma (Carcinomatosis)
03/2013 - 12/2006
3Myasthenia Gravis
02/2007 - 04/2003
3Thrombocytopenia (Thrombopenia)
01/2007 - 08/2002
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 11/2017
2Lung Neoplasms (Lung Cancer)
01/2022 - 01/2018
2Stomach Neoplasms (Stomach Cancer)
01/2021 - 01/2013
2Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2020 - 11/2019

Drug/Important Bio-Agent (IBA)

43AntigensIBA
01/2023 - 08/2002
22Proteins (Proteins, Gene)FDA Link
01/2023 - 09/2003
22Neoplasm Antigens (Tumor Antigens)IBA
01/2023 - 04/2002
22Peptides (Polypeptides)IBA
01/2021 - 04/2003
21AntibodiesIBA
02/2021 - 08/2002
18Immune Checkpoint InhibitorsIBA
01/2023 - 01/2016
17Immunoglobulin G (IgG)IBA
11/2018 - 09/2003
14Biomarkers (Surrogate Marker)IBA
01/2023 - 06/2009
12CytokinesIBA
05/2020 - 03/2004
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2021 - 07/2006
11VaccinesIBA
01/2020 - 05/2008
11AutoantibodiesIBA
07/2009 - 04/2002
10EnzymesIBA
04/2021 - 08/2002
10Small Interfering RNA (siRNA)IBA
01/2021 - 07/2004
10Complementary DNA (cDNA)IBA
12/2014 - 01/2005
9Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2020 - 10/2007
9EpitopesIBA
02/2019 - 02/2004
8DNA (Deoxyribonucleic Acid)IBA
01/2023 - 05/2003
8Cancer VaccinesIBA
01/2023 - 02/2002
8LigandsIBA
01/2021 - 09/2009
7Protein Subunit VaccinesIBA
03/2020 - 01/2017
7HLA-A Antigens (HLA-A)IBA
08/2017 - 11/2008
7Inosine Triphosphate (ITP)IBA
08/2008 - 08/2002
6ChemokinesIBA
10/2023 - 01/2013
6InterferonsIBA
01/2023 - 11/2008
6CateninsIBA
01/2022 - 03/2011
6Monoclonal AntibodiesIBA
11/2020 - 01/2003
5Interleukin-6 (Interleukin 6)IBA
08/2023 - 07/2006
4Messenger RNA (mRNA)IBA
01/2023 - 01/2010
4HLA Antigens (Human Leukocyte Antigens)IBA
01/2021 - 02/2010
4InterleukinsIBA
01/2018 - 03/2004
4HLA-A24 AntigenIBA
01/2017 - 02/2004
4ImmunosorbentsIBA
07/2015 - 08/2002
3Therapeutic UsesIBA
01/2022 - 02/2002
3NivolumabIBA
08/2021 - 11/2017
3Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 01/2017
3Docetaxel (Taxotere)FDA Link
06/2020 - 07/2018
3Carboplatin (JM8)FDA LinkGeneric
07/2018 - 01/2017
3Interleukin-10 (Interleukin 10)IBA
01/2018 - 09/2012
3Phosphotransferases (Kinase)IBA
07/2015 - 08/2004
3Interleukin-8 (Interleukin 8)IBA
04/2015 - 01/2014
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
02/2015 - 05/2003
3Interleukin-12 (IL 12)IBA
02/2015 - 07/2006
3LipopolysaccharidesIBA
08/2012 - 07/2006
3Mitogen-Activated Protein KinasesIBA
08/2012 - 08/2004
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2009 - 03/2004
3AutoantigensIBA
07/2009 - 06/2003
3Melanoma-Specific AntigensIBA
03/2005 - 04/2004
2Stearoyl-CoA DesaturaseIBA
10/2023 - 01/2022
2Immunologic Factors (Immunomodulators)IBA
10/2022 - 04/2015
2Programmed Cell Death 1 ReceptorIBA
01/2022 - 08/2021
2Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 01/2010
2Interleukin-13IBA
04/2021 - 02/2015
2HLA-A*24:02 antigenIBA
01/2021 - 01/2016
2Tyrosine Kinase InhibitorsIBA
01/2021 - 11/2017
2Cisplatin (Platino)FDA LinkGeneric
11/2020 - 01/2019

Therapy/Procedure

64Immunotherapy
10/2023 - 03/2003
39Therapeutics
10/2023 - 04/2002
11Drug Therapy (Chemotherapy)
01/2023 - 05/2012
8Hematopoietic Stem Cell Transplantation
06/2021 - 12/2005
6Cell- and Tissue-Based Therapy (Cell Therapy)
08/2021 - 09/2007
4Stem Cell Transplantation
10/2018 - 04/2004
3Transplantation
01/2016 - 12/2006
3Cryosurgery
01/2016 - 12/2006
2Chemoradiotherapy
11/2020 - 03/2020